Peptides vs SARMs: Not the Same Category

A peptide is a chain of amino acids linked by amide bonds — the same building blocks your body uses for proteins. SARMs are small synthetic organic molecules, structurally unrelated, built in a medicinal chemistry programme.

Grouping them happens because both are sold in the same online spaces to the same audiences, not because they have anything chemically in common.

SARMs — selective androgen receptor modulators — bind the androgen receptor, the same receptor testosterone acts on, with tissue selectivity as the design goal: anabolic effect in muscle and bone with less activity elsewhere.

"Peptide" names no mechanism at all. A GLP-1 agonist, a growth hormone releasing analogue and a tripeptide studied for gut signalling share a structural class and nothing functional. Asking whether peptides work is like asking whether small molecules work.

No SARM has been approved by FDA for human use. The agency has issued public warnings about them, particularly regarding liver injury and cardiovascular risk, and has taken enforcement action against sellers marketing them as supplements. They are prohibited in sport under WADA.

Peptides span the full range: approved prescription drugs, lawfully marketed supplements, and unapproved material sold as research chemicals. The category tells you nothing; the specific product tells you everything.

SARMs are associated in published case reports with drug-induced liver injury and with suppression of endogenous testosterone. Independent analyses of products sold as SARMs have repeatedly found contents that do not match the label, including unlisted compounds.

Peptide risk depends entirely on which peptide, at what dose, by what route, from what source. There is no single answer, which is itself the useful answer.

Shared retail channels, shared forum vocabulary, shared "research use only" labelling, and shared appeal to the same performance-focused audience.

Treating them as one category leads people to apply what they learned about one to the other. Both directions of that inference are wrong.